⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for childhood craniopharyngioma

Every month we try and update this database with for childhood craniopharyngioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaNCT00053963
Blastic Phase C...
Childhood Centr...
Childhood Choro...
Childhood Chron...
Childhood Crani...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Spina...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Chro...
Relapsing Chron...
Unspecified Chi...
romidepsin
- 21 YearsNational Cancer Institute (NCI)
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic ChemotherapyNCT01346267
Central Nervous...
Chemotherapy-in...
Unspecified Chi...
Real Acupressur...
Placebo Acupres...
4 Years - 18 YearsUniversity of South Florida
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsNCT00052780
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
O6-benzylguanin...
temozolomide
filgrastim
pharmacological...
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaNCT00006102
Brain and Centr...
Lymphoma
Neuroblastoma
Retinoblastoma
Sarcoma
Unspecified Chi...
becatecarin
- 21 YearsNational Cancer Institute (NCI)
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsNCT00002647
Brain and Centr...
Metastatic Canc...
verteporfin
conventional su...
3 Years - 70 YearsNational Cancer Institute (NCI)
Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By SurgeryNCT01964300
Childhood Crani...
peginterferon a...
laboratory biom...
18 Months - 25 YearsPediatric Brain Tumor Consortium
O6-benzylguanine and Carmustine in Treating Children With Refractory CNS TumorsNCT00003765
Brain and Centr...
O6-benzylguanin...
carmustine
- 21 YearsNational Cancer Institute (NCI)
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic ChemotherapyNCT01346267
Central Nervous...
Chemotherapy-in...
Unspecified Chi...
Real Acupressur...
Placebo Acupres...
4 Years - 18 YearsUniversity of South Florida
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsNCT00098761
Brain and Centr...
laromustine
- 21 YearsPediatric Brain Tumor Consortium
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic ChemotherapyNCT01346267
Central Nervous...
Chemotherapy-in...
Unspecified Chi...
Real Acupressur...
Placebo Acupres...
4 Years - 18 YearsUniversity of South Florida
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem GliomaNCT00360854
Brain and Centr...
erlotinib hydro...
mutation analys...
polymorphism an...
laboratory biom...
pharmacological...
radiation thera...
1 Year - 21 YearsNational Cancer Institute (NCI)
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsNCT00098761
Brain and Centr...
laromustine
- 21 YearsPediatric Brain Tumor Consortium
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaNCT00363272
Childhood Burki...
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Spina...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Unspecified Chi...
ispinesib
laboratory biom...
pharmacological...
1 Year - 21 YearsNational Cancer Institute (NCI)
SU5416 in Treating Children With Recurrent or Progressive Brain TumorsNCT00006247
Brain and Centr...
semaxanib
- 21 YearsPediatric Brain Tumor Consortium
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsNCT00052780
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
O6-benzylguanin...
temozolomide
filgrastim
pharmacological...
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Cilengitide in Treating Children With Refractory Primary Brain TumorsNCT00063973
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
cilengitide
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer TherapyNCT01348607
Central Nervous...
Fatigue
Specific Disord...
methylphenidate...
modafinil
placebo
8 Years - 18 YearsUniversity of South Florida
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsNCT02194452
Acoustic Schwan...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Papillary...
Adult Pilocytic...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Subependy...
Adult Supratent...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Supra...
Meningeal Melan...
Newly Diagnosed...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
gallium Ga 68-e...
positron emissi...
computed tomogr...
laboratory biom...
6 Months - 29 YearsUniversity of Iowa
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaNCT00053963
Blastic Phase C...
Childhood Centr...
Childhood Choro...
Childhood Chron...
Childhood Crani...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Spina...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Chro...
Relapsing Chron...
Unspecified Chi...
romidepsin
- 21 YearsNational Cancer Institute (NCI)
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialNCT00890435
Brain and Centr...
Leukemia
Unspecified Adu...
Unspecified Chi...
questionnaire a...
psychosocial as...
18 Years - Children's Oncology Group
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsNCT00052780
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
O6-benzylguanin...
temozolomide
filgrastim
pharmacological...
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialNCT00890435
Brain and Centr...
Leukemia
Unspecified Adu...
Unspecified Chi...
questionnaire a...
psychosocial as...
18 Years - Children's Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: